HAEMONETICS CORP — Director's Dealing 2019

Sep 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-08-30

Reporting Person: Bolorforosh Said (EVP, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-30	Common Stock	M	832	$93.52	Acquired	2973	Direct
2019-08-30	Common Stock	S	657	$133.73	Disposed	2316	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-30	Non-qualified Stock Option (Right to Buy)	$93.52	M	832	Disposed	2025-06-11	Common Stock (832)	Direct

Footnotes

F1: This number includes unvested restricted stock units previously reported.

F2: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.